Intelligence

Connecting with patients and HCPs through social media channels needs care and consistency

Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms

Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, but what impact is this having on the pharma industry?

How functional service provider models are helping pharma adapt to regulatory uncertainty

Why industry needs to engage earlier, explain value more clearly, understand service pressures and take shared responsibility for implementation

Closing the critical gap between HCPs’ need for information and the pharma industry’s ability to deliver relevant, tailored content

Why patenting should not stop at the drug candidate stage – and why coordination between researchers and attorneys is essential for strong protection

Strengthening strategic judgement during uncertainty – exploring the strategic concepts that matter most

Amazon’s entry into the GLP-1 market should be a signal to pharma that it needs to shift focus from molecule to ‘Operating Model’

A spark of creativity can cut through complexity, adding real value and helping to forge true connections with patients